Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

343 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ocular Gene Therapy.
Campbell JP, McFarland TJ, Stout JT. Campbell JP, et al. Dev Ophthalmol. 2016;55:317-21. doi: 10.1159/000434698. Epub 2015 Oct 26. Dev Ophthalmol. 2016. PMID: 26502313 Review.
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5.
Ip MS, Scott IU, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Singerman LJ, Tolentino M, Chan CK, Gonzalez VH; SCORE Study Research Group. Ip MS, et al. Arch Ophthalmol. 2009 Sep;127(9):1101-14. doi: 10.1001/archophthalmol.2009.234. Arch Ophthalmol. 2009. PMID: 19752419 Free PMC article. Clinical Trial.
A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular Edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6.
Scott IU, Ip MS, VanVeldhuisen PC, Oden NL, Blodi BA, Fisher M, Chan CK, Gonzalez VH, Singerman LJ, Tolentino M; SCORE Study Research Group. Scott IU, et al. Arch Ophthalmol. 2009 Sep;127(9):1115-28. doi: 10.1001/archophthalmol.2009.233. Arch Ophthalmol. 2009. PMID: 19752420 Free PMC article. Clinical Trial.
Epidemiologic Evaluation of Retinopathy of Prematurity Severity in a Large Telemedicine Program in India Using Artificial Intelligence.
deCampos-Stairiker MA, Coyner AS, Gupta A, Oh M, Shah PK, Subramanian P, Venkatapathy N, Singh P, Kalpathy-Cramer J, Chiang MF, Chan RVP, Campbell JP. deCampos-Stairiker MA, et al. Among authors: campbell jp. Ophthalmology. 2023 Aug;130(8):837-843. doi: 10.1016/j.ophtha.2023.03.026. Epub 2023 Apr 6. Ophthalmology. 2023. PMID: 37030453 Free PMC article.
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity.
Binenbaum G, Stahl A, Coyner AS, He J, Ying GS, Ostmo S, Chan RVP, Toth C, Vinekar A, Campbell JP; International Classification of Retinopathy of Prematurity Committee. Binenbaum G, et al. Among authors: campbell jp. Ophthalmology. 2024 Nov;131(11):1297-1303. doi: 10.1016/j.ophtha.2024.05.019. Epub 2024 May 23. Ophthalmology. 2024. PMID: 38795976 Free PMC article.
Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study.
Patel NA, Acaba-Berrocal LA, Hoyek S, Fan KC, Martinez-Castellanos MA, Baumal CR, Harper CA 3rd, Berrocal AM; Retinopathy of Prematurity Injection Consortium (ROPIC). Patel NA, et al. Ophthalmology. 2023 Apr;130(4):373-378. doi: 10.1016/j.ophtha.2022.11.012. Epub 2022 Nov 15. Ophthalmology. 2023. PMID: 36396121 Free PMC article.
Use of an Artificial Intelligence-Generated Vascular Severity Score Improved Plus Disease Diagnosis in Retinopathy of Prematurity.
Coyner AS, Young BK, Ostmo SR, Grigorian F, Ells A, Hubbard B, Rodriguez SH, Rishi P, Miller AM, Bhatt AR, Agarwal-Sinha S, Sears J, Chan RVP, Chiang MF, Kalpathy-Cramer J, Binenbaum G, Campbell JP. Coyner AS, et al. Among authors: campbell jp. Ophthalmology. 2024 Nov;131(11):1290-1296. doi: 10.1016/j.ophtha.2024.06.006. Epub 2024 Jun 10. Ophthalmology. 2024. PMID: 38866367
Downhill running does not alter blood C1q availability or complement-dependent cytotoxicity of therapeutic monoclonal antibodies against haematological cancer cell lines in vitro.
Collier-Bain HD, Brown FF, Causer AJ, Ross L, Rothschild-Rodriguez D, Browne N, Eddy R, Cleary KL, Gray JC, Cragg MS, Moore S, Murray J, Turner JE, Campbell JP. Collier-Bain HD, et al. Among authors: campbell jp. Sci Rep. 2024 Nov 15;14(1):28239. doi: 10.1038/s41598-024-79690-8. Sci Rep. 2024. PMID: 39548231 Free PMC article.
343 results